PUBLICATIONS

* Corresponding author

2018 – Publications
===============================================================================================================
113. Srivastava S.* Proteomics-based investigations of neglected and tropical diseases. Proteomics Clin Appl., (2018)

112. Mehta K, Atak A, Sahu A, Srivastava S,* C MK.* An early investigative serum Raman spectroscopy study of meningioma. Analyst, (2018)

111. Atak A, Khurana S, Gollapalli K, Reddy PJ, Levy R, Ben-Salmon S, Hollander D, Donyo M, Heit A, Hotz-Wagenblatt A, Biran H, Sharan R, Rane S, Shelar A, Ast G, Srivastava S.* Quantitative mass spectrometry analysis reveals a panel of nine proteins as diagnostic markers for colon adenocarcinomas. Oncotarget, (2018)

110. Gahoi N, Malhotra D, Moiyadi A, Varma SG, Gandhi MN, Srivastava S.* Multi-Pronged Proteomic Analysis to Study the Glioma Pathobiology using Cerebrospinal Fluid Samples. Proteomics Clin Appl., (2018)

109. Karthikaichamy A, Deore P, Srivastava S, Coppel R, Bulach D, Beardall J, Noronha S.* Temporal acclimation of Microchloropsis gaditana CCMP526 in response to hypersalinity. Bioresour Technol., (2018)

2017 – Publications
===============================================================================================================
108. Venkatesh A, Gil C, Fuentes M, LaBaer J, Srivastava S.* A Perspective on Proteomics of Infectious Diseases. Proteomics Clin Appl., (2017)

107. Jadhav M, Nayak M, Kumar S, Venkatesh A, Patel SK, Kumar V, Sharma S, Samanta B, Deb S, Karak A, Verma S, Talukdar A, Kochar SK, Mansukhani P, Gandhi M, Srivastava S.* Clinical Proteomics and Cytokine Profiling for Dengue Fever Disease Severity Biomarkers. OMICS, (2017)

106. Karthikaichamy A, Deore P, Rai V, Bulach D, Beardall J, Noronha S, Srivastava S.* Time for Multiple Extraction Methods in Proteomics? A Comparison of Three Protein Extraction Methods in the Eustigmatophyte Alga Microchloropsis gaditana CCMP526. OMICS, (2017)

105. Awasthi G, Tyagi S, Kumar V, Patel SK, Rojh D, Sakrappanavar V, Kochar SK, Talukdar A, Samanta B, Das A, Srivastava S, Patankar S. A Proteogenomic Analysis of Haptoglobin in Malaria. Proteomics Clin Appl., (2017)

104. Gupta S, Mukherjee S, Syed P, Pandala NG, Choudhary S, Singh VA, Singh N, Zhu H, Epari S, Noronha SB, Moiyadi A, Srivastava S.* Evaluation of autoantibody signatures in meningioma patients using human proteome arrays. Oncotarget, (2017)

103. Venkatesh A, Lahiri A, Reddy PJ, Shastri J, Bankar S, Patankar S, Srivastava S.* Identification of Highly Expressed Plasmodium Vivax Proteins from Clinical Isolates Using Proteomics. Proteomics Clin Appl., (2017)

102. Gupta S, Manubhai KP, Mukherjee S, Srivastava S.* Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays. Methods Mol Biol., (2017)

101. Ray S, Patel SK, Venkatesh A, Chatterjee G, Ansari NN, Gogtay NJ, Thatte UM, Gandhe P, Varma SG, Patankar S, Srivastava S.* Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection. Sci Rep., (2017)

100. Gollapalli K, Ghantasala S, Atak A, Rapole S, Moiyadi A, Epari S, Srivastava S.* Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis. OMICS, (2017)

99. Gollapalli K, Ghantasala S, Kumar S, Srivastava R, Rapole S, Moiyadi A, Epari S, Srivastava S.* Subventricular zone involvement in Glioblastoma – A proteomic evaluation and clinicoradiological correlation. Sci Rep., (2017)

98. Rai V, Muthuraj M, Gandhi MN, Das D, Srivastava S.* Real-time iTRAQ-based proteome profiling revealed the central metabolism involved in nitrogen starvation induced lipid accumulation in microalgae. Sci Rep., (2017)

97. Jain R, Atak A, Yeola A, Srivastava S.* Proteomic level changes associated with S3I201 treated U87 glioma cells. J Proteomics. (2017)

96. Özdemir V, Dove ES, Gürsoy UK, Şardaş S, Yıldırım A, Yılmaz ŞG, Ömer Barlas I, Güngör K, Mete A, Srivastava S.* Personalized medicine beyond genomics: alternative futures in big data-proteomics, environtome and the social proteome. J Neural Transm (Vienna), (2017)

2016 – Publications
===============================================================================================================

95. Kumar R, Srivastava S.* Quantitative proteomic comparison of stationary/G0 phase cells and tetrads in budding yeast. Sci Rep., (2016)

94. Atak A, Mukherjee S, Jain R, Gupta S, Singh VA, Gahoi N, K P M, Srivastava S.* Protein microarray applications: Autoantibody detection and posttranslational modification. Proteomics, (2016)

93. Venkatesh A, Patel SK, Ray S, Shastri J, Chatterjee G, Kochar SK, Patankar S, Srivastava S.* Proteomics of Plasmodium vivax malaria: new insights, progress and potential. Expert Rev Proteomics, (2016)

92. Rai V, Karthikaichamy A, Das D, Noronha S, Wangikar PP, Srivastava S.* Multi-omics Frontiers in Algal Research: Techniques and Progress to Explore Biofuels in the Postgenomics World. OMICS, (2016)

91. Saygılı Eİ, Abou-Zeid AH, Akkın SM, Aklillu E, Barlas İÖ, Borda-Rodriguez A, Boschele FA, Çetin Z, Coşkun E, Coşkun Y, Dağlı G, Dai TU, Dandara C, Dereli T, Elbeyli L, Endrenyi L, Eyigün CP, Georgakilas A, Günbulut B, Güngör K, Güzelbey A, Hekim C, Huzair F, Kimyon S, Karakaş Ü, Lin B, LLerena A, Masimirembwa C, McNally R, Mete A, Sancar P, Srivastava S, Steuten LM, Tanrıöver O, Tyfield D, Töre Vİ, Vuruşkan D, Wang W, Warnich L, Wonkam A, Yıldırım YZ, Yılmaz İ, Sınav A, Hekim N. An Open Letter in Support of Transformative Biotechnology and Social Innovation: SANKO University Innovation Summit in Medicine and Integrative Biology. OMICS, (2016)

90. Atak A, Mehta K, Rao A, Gollapalli K, Manubhai KP, Gandhi M, Nayak M, Gahoi N, Reddy PJ, Jain R, Ghantasala S, Gupta S, Mukherjee S, Pillai T, Singh VA, Mani VA, Pandey V, Srivastava S.* Targeted Proteomics Workshop and International Symposium (IIT Bombay, Mumbai, India): An Accelerator for Global Proteomics. OMICS, (2016)

89. Ray S†, Patel SK†, Venkatesh A, Bhave A, Kumar V, Singh V, Chatterjee G, Shah VG, Sharma S, Renu D, Nafis N, Gandhe P, Gogtay N, Thatte U, Sehgal K, Verma S, Karak A, Khanra D, Talukdar A, Kochar SK, S B V, Kochar DK, Rojh D, Varma SG, Gandhi MN, Srikanth R, Patankar S, Srivastava S. Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria. Sci Rep., (2016)

88. Gupta S, Manubhai KP, Kulkarni V, Srivastava S.* An overview of innovations and industrial solutions in Protein Microarray Technology. Proteomics, (2016)

87. Srivastava S.* Protein arrays: promises and potential for the translational research. Proteomics, (2016)

86. Paul D, Chanukuppa V, Reddy PJ, Taunk K, Adhav R, Srivastava S, Santra MK, Rapole S. Global proteomic profiling identifies etoposide chemoresistance markers in non-small cell lung carcinoma. J Proteomics, (2016)

2015 – Publications
===============================================================================================================
85. Sahu AK, Dhoot S, Singh A, Sawant SS, Nandakumar N, Talathi-Desai S, Garud M, Pagare S, Srivastava S., Nair S, Chaturvedi P, Murali Krishna C., Oral cancer screening: serum Raman spectroscopic approach. J Biomed Opt., (2015)

84. Srivastava S.*, Special Issue “Proteomics in India”: Gazing Forward while Reflecting on the Lessons Learned in Global Proteomics., J Proteomics, (2015)

83. Ray S, Bhave A, Srivastava S.* Brainstorming the New Avenues for Translational Proteomics Research: First Indo-US Bilateral Proteomics Workshop. Current Proteomics, (2015)

82. Sadhu S, Gandhi M, Srivastava S.* Lanthenide-doped Nanophosphor labels for Protein Microarrays. 2015 Current Pharmacogenomics and Personalized Medicine, (2015)

81. Grover Shah V, Ray S, Karlsson R, Srivastava S.*, Calibration-free concentration analysis of protein biomarkers in human serum using surface plasmon resonance, Talanta, (2015)

80. Syed, P., Gupta, S., Choudhary, S., Pandala, N.G., Atak, A., Richharia, A., K P, M., Zhu, H., Epari, S., Noronha, S.B., Moiyadi A., Srivastava S.*. Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays. Sci. Rep., (2015)

78. Ray S, Kumar V, Bhave A, Singh V, Gogtay NJ, Thatte UM, Talukdar A, Kochar SK, Patankar S, Srivastava S.* Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J Proteomics, (2015)

77. Gupta S, Reddy P J, Ray S, Atak A, Gollapalli K, Jain R, Shah G V, Ghantasala S, Kumar S, Pandala N G, Phapale P, Pandey V K, Zingde SM, Srivastava S.* Proteomics from Discovery to Function: Annual meeting of Proteomics Society India and International Conference. OMICS A Journal of Integrative Biology, (2015)

76. Reddy PJ, Atak A, Ghantasala S, Kumar S, Gupta S, Prasad TS, Zingde SM, Srivastava S.* Proteomics research in India: An update. J Proteomics, (2015)

75. Reddy PJ, Ray S, Srivastava S.* The quest of the human proteome and the missing proteins: digging deeper. OMICS A Journal of Integrative Biology, (2015)

74. Reddy PJ, Sinha S, Ray S, Sathe GJ, Chatterjee A, Prasad TS, Dhali S, Srikanth R, Panda D, Srivastava S.* Comprehensive analysis of temporal alterations in cellular proteome of Bacillus subtilis under curcumin treatment. PLoS One, (2015)

73. Özdemir V, Faris J, Srivastava S. Crowdfunding 2.0: the next-generation philanthropy: A new approach for philanthropists and citizens to co-fund disruptive innovation in global health. EMBO Rep, (2015)

72. Reddy PJ, Ray S, Sathe GJ, Prasad TS, Rapole S, Panda D, Srivastava S. Proteomics Analyses of Bacillus subtilis after Treatment with Plumbagin, a Plant-Derived Naphthoquinone. OMICS, (2015)

71. Reddy PJ, Ray S, Sathe GJ, Gajbhiye A, Prasad TS, Rapole S, Panda D, Srivastava S. A comprehensive proteomic analysis of totarol induced alterations in Bacillus subtilis by multipronged quantitative proteomics. J Proteomics, (2015)

70. Sharma S, Ray S, Mukherjee S, Moiyadi A, Sridhar E, Srivastava S. Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics, (2015)

69. Gahoi N, Ray S, Srivastava S. Array-based proteomic approaches to study signal transduction pathways: Prospects, merits and challenges. Proteomics, (2015)

68. Jain R, Kulkarni P, Dhali S, Rapole S, Srivastava S. Quantitative proteomic analysis of global effect of LLL12 on U87 cell’s proteome: An insight into the molecular mechanism of LLL12. J Proteomics, (2015)

2014 – Publications
===============================================================================================================

67. Sharma S, Ray S, Moiyadi A, Sridhar E, Srivastava S. Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers. Sci Rep, (2014)

66. Kumar R, Dhali S, Srikanth R, Ghosh SK, Srivastava S. Comparative proteomics of mitosis and meiosis in Saccharomyces cerevisiae. J Proteomics, (2014)

65. Hekim N, Coşkun Y, Sınav A, Abou-Zeid AH, Ağırbaşlı M, Akintola SO, Aynacıoğlu Ş, Bayram M, Bragazzi NL, Dandara C, Dereli T, Dove ES, Elbeyli L, Endrenyi L, Erciyas K, Faris J, Ferguson LR, Göğüş F, Güngör K, Gürsoy M, Gürsoy UK, Karaömerlioğlu MA, Kickbusch I, Kılıç T, Kılınç M, Kocagöz T, Lin B, LLerena A, Manolopoulos VG, Nair B, Özkan B, Pang T, Sardaş Ş, Srivastava S, Toraman C, Üstün K, Warnich L, Wonkam A, Yakıcıer MC, Yaşar Ü, Özdemir V. Translating biotechnology to knowledge-based innovation, peace, and development? Deploy a Science Peace Corps–an open letter to world leaders. OMICS, (2014)

64. Ozdemir V, Endrenyi L, Aynacıoğlu S, Bragazzi NL, Dandara C, Dove ES, Ferguson LR, Geraci CJ, Hafen E, Kesim BE, Kolker E, Lee EJ, Llerena A, Nacak M, Shimoda K, Someya T, Srivastava S, Tomlinson B, Vayena E, Warnich L, Yaşar U. Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics). OMICS, (2014)

63. Moiyadi A, Syed P, Srivastava S. Fluorescence-guided surgery of malignant gliomas based on 5-aminolevulinic acid: paradigm shifts but not a panacea. Nat Rev Cancer, (2014)

62. Kolker E, Özdemir V, Martens L, Hancock W, Anderson G, Anderson N, Aynacioglu S, Baranova A, Campagna SR, Chen R, Choiniere J, Dearth SP, Feng WC, Ferguson L, Fox G, Frishman D, Grossman R, Heath A, Higdon R, Hutz MH, Janko I, Jiang L, Joshi S, Kel A, Kemnitz JW, Kohane IS, Kolker N, Lancet D, Lee E, Li W, Lisitsa A, Llerena A, Macnealy-Koch C, Marshall JC, Masuzzo P, May A, Mias G, Monroe M, Montague E, Mooney S, Nesvizhskii A, Noronha S, Omenn G, Rajasimha H, Ramamoorthy P, Sheehan J, Smarr L, Smith CV, Smith T, Snyder M, Rapole S, Srivastava S, Stanberry L, Stewart E, Toppo S, Uetz P, Verheggen K, Voy BH, Warnich L, Wilhelm SW, Yandl G. Toward more transparent and reproducible omics studies through a common metadata checklist and data publications. OMICS, (2014)

61. Özdemir V, Kolker E, Hotez PJ, Mohin S, Prainsack B, Wynne B, Vayena E, Coşkun Y, Dereli T, Huzair F, Borda-Rodriguez A, Bragazzi NL, Faris J, Ramesar R, Wonkam A, Dandara C, Nair B, Llerena A, Kılıç K, Jain R, Reddy PJ, Gollapalli K, Srivastava S, Kickbusch I. Ready to put metadata on the post-2015 development agenda? Linking data publications to responsible innovation and science diplomacy. OMICS. (2014)

60. Gupta S, Venkatesh A, Ray S, Srivastava S. Challenges and prospects for biomarker research: a current perspective from the developing world. Biochim Biophys Acta, (2014)

59. Ray S, Patel SK, Kumar V, Damahe J, Srivastava S. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures. Proteomics Clin Appl, (2014)

58. Diwakar S, Parasuram H, Medini C, Raman R, Nedungadi P, Wiertelak E, Srivastava S, Achuthan K, Nair B. Complementing Neurophysiology Education for Developing Countries via Cost-Effective Virtual Labs: Case Studies and Classroom Scenarios, The Journal of Undergraduate Neuroscience Education (JUNE), Spring 2014.

2013 – Publications
===============================================================================================================

57. Srivastava S, Özdemir V, Ray S, Panga JR, Noronha S, Nair B, Diwakar S. Online education: E-learning booster in developing world. Nature, (2013)

56. Ray S, Moiyadi A, Srivastava S. Epidemiology: Biorepositories for cancer research in developing countries. Nat Rev Clin Oncol, (2013)

55. Reddy P.J., Rao A.A, Malhotra D., Sharma S., Kumar R., Jain R., Gollapalli K., Pendharkar N., Srikanth R., Srivastava S*. A simple protein extraction method for proteomic analysis of diverse samples. Current Proteomics, 2013 (in press).

54. Ray S, Patel S, Kumar V, Damahe J., Srivastava S. Differential expression of serum/plasma proteins in various infectious diseases: overlapping and inimitable signatures. Proteomics Clinical Applications, 2013 (in press).

53. Srivastava S, Özdemir V, Ray S, Panga JR, Noronha S, Nair B, Diwakar S. et al. E-learning booster in developing world. Nature, 2013, 501, 316.

52. Rao AA, Patkari M, Reddy PJ, Srivastava R, Pendharkar N, Srikanth R, Mehra S, Srivastava S*. Proteomic analysis of Streptomyces coelicolor in response to Ciprofloxacin challenge. J Proteomics. 2013 Aug 28. doi:pii: S1874-3919(13)00454-5.

51. Mehta D.G, Kumar R, Srivastava S*, Ghosh S.K. Cohesin: functions beyond sister chromatid cohesion. FEBS Letters, 2013, 587, 2299-2312.

50. Kolker E. (Sanjeeva Srivastava and co-signatories). Reproducibility: In praise of open research measures. Nature,2013, 498 (7453), 170.

49. Özdemir V, LLerena A, McKinnon R.A, Srivastava S*, Dove E.S., Ferguson L.R., Masellis M., Nair B., Gurwitz D., Warnich L. CPPM 2013 onward: building a socio-technical GPS for global personalized medicine – A welcome to Editors-In-Chief Adrián LLerena (Spain) and Ross A. McKinnon (Australia). Current Pharmacogenomics and Personalized Medicine, 2013, 11, 87-92.

48. Pachapur V., Kapoor A., Jain R., Singh P., Renu D., Dikshit J.B., Srivastava S*. Systems biology approach for the identification of diagnostic and therapeutic targets in medulloblastomas. Current Pharmacogenomics and Personalized Medicine, 2013, 11, 137-153.

47. Jain R, Pachapur V, Kapoor A, Vasavada M.S, Singh P, Renu D, Dikshit J.B, Srivastava S*. An integrative systems analysis of high-grade glioma cell lines: TLRs, Wnt, BRCA1, Netrins, STXBP1 and MDH1 provide putative molecular targets for therapeutic intervention. Current Pharmacogenomics and Personalized Medicine, 2013, 11, 118-136.

46. Ozdemir V, Badr K.F, Dove E.S, Endrenyi L, Geraci C.J, Hotez P.J, Milius D, Pereira M.N, Pang T, Rotimi C.N, Sabra R, Sarkissian C.N, Srivastava S* et al. Crowd-funded micro-grants for genomics and ‘‘big data’’: An actionable idea connecting small (artisan) science, infrastructure science, and citizen philanthropy. OMICS A Journal of Integrative Biology,2012, 17 (4), 161-172.

45. Konvalinka A, Srivastava S*, Masellis M. (2013) Taking the kidney personally: The quest for novel antigens of idiopathic membranous nephropathy through proteomic approaches – Per Ardua Ad Astra?. Current Pharmacogenomics and Personalized Medicine, 2013, 11, 5-7.

44. Özdemir V, Rodriguez A.B, Dove E.S, Ferguson L.R, Huzair F, Manolopoulos V.G, Masellis M, Milius D, Warnich L, Srivastava S*. Public health pharmacogenomics and the design principles for global public goods – moving genomics to responsible innovation. Current Pharmacogenomics and Personalized Medicine, 2013,11,1-4.

43. Malhotra D, Diwakar S, Ozdemir V, Nair B and Srivastava S*. (2013) BIOQUEST India: A Global Biotechnology Forum for Knowledge-Based Innovation and Sustainable Development.CurrentPharmacogenomics Person Med, 11(1): 8-11.

2012 – Publications
===============================================================================================================

42. Ray S, Renu D, Srivastava R, Gollapalli K, Taur S, Jhaveri T, Dhali S, Chennareddy S, Potla A, Dikshit JB, Srikanth R, Gogtay N, Thatte U,Patankar S,Srivastava S.* (2012) Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One, 7(8): e41751.

41. Ray S, Srivastava R, Tripathi K, Vaibhav V, Srivastava S.* (2012) Serum proteome changes in dengue virus-infected patients from a dengue-endemic area of India: towards new molecular targets?. OMICS, 16(10), 527-36.

40. Ray S, Kamath KS, Srivastava R, Raghu D, Gollapalli K, Jain R, Gupta SV, Ray S, Taur S, Dhali S, Gogtay N, Thatte U, Srikanth R, Patankar S, Srivastava S.* (2012) Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response. J Proteomics 75(10), 3063-3080.

39. Gollapalli K, Ray S, Srivastava R, Renu D, Singh P, Dhali S, Dikshit JP, Srikanth R, M. Aliasgar and Srivastava S.* (2012) Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics 12(14), 2378-2390.

38.  Ray S., Koshy N.R. and Srivastava S.* (2012) Sakshat Labs and Virtualization in Proteomics. Plos Biology 10(7), e1001353.  doi:10.1371/journal.pbio.1001353.

37. Srivastava R., Ray S., Vaibhav V, Gollapalli K., Jhaveri T., Taur S., Dhali S., Gogtay N., Thatte U., Srikanth R. and Srivastava S.* (2012) Serum profiling of leptospirosis patients to investigate proteomic alterations. J Proteomics 76, 56-68.

36. Ray S., Koshy N.R., Reddy P.J. and Srivastava S.* (2012) Virtual Labs in proteomics: New E-learning tools. J Proteomics 75(9), 2515-2525.

35. Jain R., Dasgupta A., Moiyadi A., Srivastava S.* (2012) Transcriptional Analysis of JAK/STAT Signaling in Glioblastoma Multiforme. Curr Pharmacogenomics Person Med 10(1) , 54-69.

34. Reddy P.J., Sadhu S., Ray S., Srivastava S.* (2012) Cancer biomarker detection by surface plasmon resonance biosensors. Clin Lab Med 32(1), 47-72.

2011 – Publications
===============================================================================================================

33. Ozdemir V., Rosenblatt D.S., Warnich L., Srivastava S.*, Tadmouri G.O., Aziz R.K., Reddy P.J., Manamperi A., Dove E.S., Joly Y., Zawati M.H., Hızel C., Yazan Y., John L., Vaast E., Ptolemy A.S., Faraj S.A., Kolker E., Cotton R.G.H. (2011) Towards an ecology of collective innovation. Curr Pharmacogenomics Person Med 9(4), 243-251.

32. Ray S., Ray S., D’souza, Srivastava S.* (2011) Nanotechniques and proteomics: An integrated platform for diagnostics, targeted therapeutics and personalized medicine. Current Pharmacogenomics Person Med 9(4) ,264-285.

31. Kamath K.S., Vasavada M. and Srivastava S.* (2011) Proteomic databases and tools to decipher post-translational modifications. Journal of Proteomics 75(1), 127-144.

30. Reddy P.J., Jain R., Paik Y., Downey R., Ptolemy A.S., Ozdemir V., Srivastava S.* (2011) Personalized medicine in the age of pharmacoproteomics: A close up on India and need for social science engagement for responsible innovation in post-proteomic biology. Current Pharmacogenomics and Personalized Medicine 2011, 9, 159-167.

29. Kamal S. M., Warnich L., Ferguson L. R., Srivastava S.* , Ray S., Avard D., Joly Y., Le Huynh M., Page M., Masellis M., Dove E. S., Gurwitz D., Ozdemir V. (2011) Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 st Century Postgenomics Global Health — A Close Up on Africa and Women’s Health. Current Pharmacogenomics and Personalized Medicine 2011, 9, 148-155.

28. Ray S., Jaipal P., Choudhary S., Raghu D., Srivastava S.* (2011) Emerging nanoproteomics approaches for disease diagnosis: a current perspective. Journal of Proteomics 74(12), 2660-2681.

27. Ray S., Jaipal P., Jain R., Gollapalli K., Moiyadi A., Srivastava S.* (2011) Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 11, 2139-61.

26. Chandra H., Reddy J., Srivastava S.* (2011) Protein microarrays and novel detection platforms. Expert Opinion in Proteomics 8, 61-79.

25. Chatterji B.P., Jindal B., Srivastava S., Panda D. (2011) Microtubules as antifungal and antiparasitic drug targets. Expert Opin Ther Patents 21, 1-20.

2010 – Publications
===============================================================================================================
24. Ray S., Chandra H. and Srivastava S.* (2010) Nanotechniques in proteomics: current status, promises and challenges. Biosens Bioelectron 25, 2389-2401.

23. Ray S., Mehta G. and Srivastava S.* (2010) Label-free detection techniques for protein microarrays: prospects, merits and challenges. Proteomics 10, 731-48.

22. Chandra H. and Srivastava S.* (2010) Cell-free synthesis based protein microarrays and their applications. Proteomics 10, 717-30.

During postdoctoral research (Harvard University, USA).

21. Srivastava S. and LaBaer J. (2008) Nanotubes light up protein arrays. Nature Biotechnology 26, 1244-1246.

20. Srivastava S., Ramachandran N. and LaBaer J. (2008) Applications of protein microarrays for biomarker discovery. Proteomics Clinical Applications 2, 1444-14459.

During graduate research (University of Alberta, Canada)

19. Mohammadi M., Srivastava S., Hall J.C., Kav N.N. and Deyholos M.K. (2012) Two Wheat (Triticum aestivum) Pathogenesis-Related 10 (PR-10) Transcripts with Distinct Patterns of Abundance in Different Organs. Mol Biotechnol 51(2),103-108.

18. Krishnaswamy S., Srivastava S., Mohammadi M., Rahman M.H., Deyholos M.K. and Kav N.N.V. (2008) Transcriptional profiling of pea ABR17 mediated changes in gene expression in Arabidopsis thaliana. BMC Plant Biology 8, 9(1-19).

17. Liang Y., Srivastava S., Strelkov S. and Kav N.N.V. (2008) Proteome-level changes in susceptible Brassica napus infected by Sclerotinia sclerotiorum. Journal of Agriculture and Food Chemistry 56, 1963-1976.

16. Cao T., Srivastava S., Rahman M.H., Kav N.N.V., Hotte N., Deyholos M.K. and Strelkov S.E. (2008) Proteomic changes in the roots of Brassica napus in response to infection by Plasmodiophora brassicae. Plant Science 174, 97–115.

15. Srivastava S., Rahman H., Emery R.J.N. and Kav N.N.V. (2007) A crucial role for cytokinins in pea ABR17-mediated enhanced germination and early seedling growth of Arabidopsis thaliana under saline and low temperature stresses. Journal of Plant Growth Regulation 26, 26–37.

14. Yang B., Srivastava S., Deyholos M.K. and Kav N.N.V. (2007) Transcriptional profiling of canola (Brassica napus L.) responses to the fungal pathogen Sclerotinia sclerotiorum. Plant Science 173, 156-171.

13. Dunfield K., Srivastava S., Shah S. and Kav N.N.V. (2007) Constitutive expression of ABR17 cDNA enhances germination and promotes early flowering in Brasscia napus. Plant Science 173, 521-532.

12. Kav N.N.V., Srivastava S., Yajima W. and Sharma N. (2007) Application of proteomics to investigate plant-microbe interactions. Current Proteomics 4, 28-43.

11. Srivastava S., Rahman H., Shah S. and Kav N.N.V. (2006) Constitutive expression of pea ABR17 cDNA confers multiple stress tolerance in Arabidopsis thaliana. Plant Biotechnology Journal 4, 529-549.

10. Srivastava S., Emery R.J.N., Kurepin L.V., Reid D.M., Fristensky B. and Kav N.N.V. (2006) Pea PR 10.1 is a ribonuclease and its transgenic expression elevates cytokinin levels. Plant Growth Regulation 49, 17-25.

9. Srivastava S., Jain S., Sarin N. and Kav N.N.V. (2006) Increase in levels of pathogenesis-related (PR) 10 proteins in saline-tolerant Arachis hypogaea L. calli. Plant Physiology and Biochemistry 44, 253-259.

8. Srivastava S., Fristensky B. and Kav N.N.V. (2004) Constitutive expression of a PR 10 protein enhances the germination of Brassica napus under saline conditions. Plant and Cell Physiology 45, 1320-1324.

7. Kav N.N.V., Srivastava S., Goonewardene L. and Blade S. (2004) Proteome-level changes in the roots of Pisum sativum L. in response to salinity. Annals of Applied Biology 145, 217-230.

Book chapter

5. Spera R., Badino F., Hainsworth, G., Fuentes, M., Srivastava, S., LaBaer, J., Nicolini, C. (2010) Label free detection of NAPPA via mass spectrometry. In: Functional proteomics & Nanotechnology-based microarrays. Pan Stanford Series on Nanobiotechnology Volume 2, page 61-78.

4. Fuentes, M., Srivastava, S., Ramachandran N., Hainsworth, G., LaBaer, J. (2010) Label-free detection of NAPPA: Surface Plasmon Resonance. Volume 2. Pan Stanford Series on Nanobiotechnology 2010.

3. Kav N.N.V., Srivastava S., Yajima W. and Ali S. (2008) “Proteomics in developing countries”. In: Plant proteomics: Technologies, strategies, and applications (Eds: Ganesh K. Agrawal and Randeep Rakwal), Wiley-Interscience, USA 570-581.

2. Kav N.V.V., Yajima W., Sharma N., Srivastava S. and Krishnaswamy, S. (2007) Crop Improvement (The ‘Gene’ Revolution), in Animal and Plant Productivity, (Ed: Robert J. Hudson), in Encyclopedia of Life Support Systems (EOLSS), Developed under the Auspices of the UNESCO, Eolss Publishers, Oxford, UK.

1. Srivastava S., Ali S. and Kav N.N.V. (2005) An overview on proteomics. In: Biotechnology in the welfare of mankind (Eds: I. A. Khan and A. Khanum), Volume II, Ukaaz Publications, Hyderabad, India 179-253.

Patent

4. IPA 1907/MUM/2012 – Sanjeeva Srivastava, Rajneesh Srivastava, Sandipan Ray, Vineet Vaibhav. Protein biomarkers for Leptospirosis. Published – 30-5-2014

3. IPA 2195/Mum/2012 – Sanjeeva Srivastava, Sandipan Ray, Swati Patankar, Sanjeeva Srivastava, Durairaj Renu, Jyoti Bajpai Dikshit, Kas Subramanian, Santosh Taur, Nithya Gogtay, Urmila Thatte. Identification of surrogate protein markers for Falciparum and Vivax malaria using proteomic approaches. Published – 5-9-2014

2. IPA 2587/MUM/2015 – Label-free method for detection and quantification of protein biomarkers

1. Kav N.N.V., Srivastava S. and Shah S. (2008) Method of conferring multiple stress tolerance and early flowering in plants. United States Patent 20080005810.

Recent conferences

5. Srivastava S. Advances in Microarray Technology, Dublin, Ireland, May 25-26, 2010) – Poster presentation.

4. Srivastava S. , Fuentes, M. and LaBaer, J. International conference –6th Annual US HUPO Conference – Proteomics from bench to clinic, Denver, USA, March 7-10, 2010 – Poster presentation.

3. Srivastava S. International conference – 5th AOHUPO Congress, 14th ADNAT Convention & 1st PSI Conference On New Perspectives in Proteome Research, Feb 21-25, 2010 – Oral presentation.

2. Srivastava S. National conference – Young Explorers in Indian Biology (YEIB), TIFR, Mumbai, India, Sep 15, 2009 – Oral presentation.

1. Srivastava S. International conference – International Symposium of emerging areas in Biosciences and Bioengineering (ISEABB), IIT Bombay, Mumbai, India, Feb 26-28, 2009 – Oral presentation.

Facebook
Twitter
LinkedIn